NR3C1 and rheumatoid arthritis: Future translational studies are warranted to explore the effects of novel drugs on MSK diseases, such as PD-1 agonist (peresolimab) and antibody-drug conjugate (composed of anti-TNF monoclonal antibody linked to a glucocorticoid receptor modulator) for RA.24